In March 2026, the UK’s National Institute for Health and Care Excellence (NICE) formally recommend the cryoablation for treating kidney (renal) tumours.
In this episode, Dr David Breen, consultant abdominal radiologist at University Hospital Southampton (UHS), discusses cryoablation’s value in treating kidney tumours, and the implications of NICE’s formal recommendation for the technology’s use in kidney cancer treatment, among other topics.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Listen to the full episode below:
